Industry Focus

Reach us by Email @ IndustryFocus@fool.com

Tech: 8 2021 IPOs in 40 Minutes Jul 16, 2021

Show notes

Almost a quarter of our shows so far in 2021 have been breakdowns of newly public companies.

On today's show, we revisit all the businesses we looked at in the first half of the year, get up to speed on their latest results, and talk about which ones are our favorites.

Stocks: OLO, PATH, S, GLBE, SQSP, KNBE, RAAC, AFRM.

Check out more of our content here:

Reach us by Email @ IndustryFocus@fool.com

Energy: NPR’s Jacob Goldstein on Bitcoin, Inflation, and the Economy Jul 15, 2021

Show notes

NPR’s Jacob Goldstein returns to the show for a wide-ranging conversation with Jason Hall and Nick Sciple about the cryptocurrency market, inflation, housing, and more.

Investments Discussed: Bitcoin

Check out more of our content here:

Reach us by Email @ IndustryFocus@fool.com

Wildcard: The Next Nano-X, But With Less Risk Jul 14, 2021

Show notes

HyperFine is looking to head to public markets with the lofty goal of disrupting the MRI market with the first FDA-approved portable MRI machine. Join Brian Feroldi and Emily Flippen as they break down HyperFine’s roadshow and unpack this recent SPAC.

Stocks: HealthCor Catalio Acquisition Corp (HCAQ)

Check out more of our content here:

Reach us by Email @ IndustryFocus@fool.com

CG: Has Crocs Overcome Getting off on the Wrong Foot? Jul 13, 2021

Show notes

Crocs is perhaps the most controversial footwear brand of all time, creating both blind loyalists and uncompromising cynics. Regardless of what side of the fence you may fall on, Crocs have skyrocketed in popularity over the past few years as brand deals, endorsements, and Gen Z flocked to the Croc. Join Motley Fool Analysts Asit Sharma and Emily Flippen as they take a look at where Crocs has been and if the best is still yet to come.

*** Editor's note: In the podcast and in the accompanying transcript below, our analysts described Croc's Croslite formulation as "patented." This was an error. Croc's croslite formulation is proprietary, but not patented.

Stocks: Crocs (CROX)

Check out more of our content here:

Reach us by Email @ IndustryFocus@fool.com

Financials: Earnings Season, SPACs, and More Jul 12, 2021

Show notes

Wells Fargo (NYSE: WFC) recently decided to shut down its personal lines of credit business. Why did the bank make this move, and is it unfair to customers? Plus, SPACs are back in the news after Virgin Galactic's (NYSE: SPCE) successful flight with founder Richard Branson. Plus, host Jason Moser and Fool.com contributor discuss what they'll be watching as banks report their earnings later this week.

Check out more of our content here:

Reach us by Email @ IndustryFocus@fool.com

Tech: Bienvenu Duolingo! Jul 09, 2021

Show notes

We talk Duolingo (and a bit of Spanish and French) on today's episode.

Listen in for a breakdown of how this app uses the freemium model to make language education easy and accessible, whether the company's books look bien or mal, and why the CEO's track record is something to be excited about.

Check out more of our content here:

Reach us by Email @ IndustryFocus@fool.com

Energy: Is Linde lindy? Jul 08, 2021

Show notes

Motley Fool Senior Analyst John Rotonti joins the podcast to break down the industrial gas industry and the case for investing in industrial gas giant (and Dividend Aristocrat) Linde.

Stocks Discussed: LIN, APD, AIQUY

Check out more of our content here:

Reach us by Email @ IndustryFocus@fool.com

Wildcard: Can These Stocks Deliver 10x Returns? Jul 07, 2021

Show notes

Join Brian Feroldi as he walks you through three small cap healthcare companies that may have flown under your radar with the aim of answering the question every investor wants to know: can this business result in 10x returns?

Stocks: Progyny (PGNY), Pulmonx (LUNG), and Nano-X Imaging (NNOX)

Check out more of our content here:

Reach us by Email @ IndustryFocus@fool.com

CG: The Next Decade of Dating Jul 06, 2021

Show notes

Join Analysts Asit Sharma and Emily Flippen as they take a look at the online dating industry, including dating trends coming out of the coronavirus pandemic as well as two of the biggest competitors: Match Group (MTCH) and Bumble (BMBL)

Check out more of our content here: